Obstetric and vascular APS: Same autoantibodies but different diseases?

P. L. Meroni, E. Raschi, C. Grossi, F. Pregnolato, L. Trespidi, B. Acaia, M. O. Borghi

Research output: Contribution to journalArticlepeer-review


Beta2 glycoprotein I (β2GPI)-dependent antiphospholipid antibodies (aPLs) are the main pathogenic autoantibody population and at the same time the laboratory diagnostic tool for the antiphospholipid syndrome (APS).These antibodies are responsible for both the vascular and the obstetric manifestations of the syndrome but the pathogenic mechanisms behind these manifestations are not the same. For example, thrombotic events do not appear to play a major role in APS miscarriages and a direct reactivity of β2GPI-dependent aPLs on decidual and trophoblast cells was reported. A local expression of β2GPI on these tissues was reported both in physiological conditions and in APS women, thus explaining the local tropism of the autoantibodies.The two hit hypothesis was suggested to explain why the vascular manifestations of APS may occur only occasionally in spite of the persistent presence of aPLs. This is not apparently the case for the obstetric variant of the syndrome, making the difference even more striking. A different pathogenesis may also provide the rationale for the well-known fact that the vascular and the obstetric manifestations may occur independently although in a minority of cases.

Original languageEnglish
Pages (from-to)708-710
Number of pages3
Issue number7
Publication statusPublished - Jun 2012


  • anti-β2GPI antibodies
  • Antiphospholipid syndrome
  • pregnancy
  • thrombosis

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Obstetric and vascular APS: Same autoantibodies but different diseases?'. Together they form a unique fingerprint.

Cite this